Quality · Access · Hope
Countries

🇴🇲 Country Profile

Oman

Fast-growing pharmaceutical trade with Oman

🇴🇲 $60.0M
All data from DGCIS India export records (fiscal year, April–March).
$60.0M
Scale
Oman's healthcare system receives $60.0M in Indian pharmaceutical products each year — affordable, quality medicine.
66%
Medicine
Primarily medicines (66%), supplemented by medicine ingredients and surgical & hospital supplies.
3.7×
Trajectory
One of the faster-growing relationships — India's pharmaceutical supply to Oman has expanded 3.7× over the decade.
Context
Part of India's pharmaceutical supply network across Middle East.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Oman — building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharma categories from DGCIS (487-code basket)

Category Mix — FY 2025–26 DGCIS
Medicines $39.8M (66.2%) Medicine Ingredients $14.7M (24.5%) Surgical & Hospital Supplies $3.0M (5.0%) Traditional & Herbal $1.4M (2.4%) Vaccines $1.1M (1.9%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Oman Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Oman: $2.0M across 3 filings (2012-2013).